The first is a direct enhancement of effector T-cell responses through simple blockade of CTLA-4—‘releasing the brakes’, while the second requires prior elimination of regulatory T cells (TREG) to allow emergence of T-cell-mediated destruction of tumour cells. Here, CTLA4 is linked to neoplasm.